Market Place
Sourcing Support
Biostem Reports $102.9M Q4 Revenue, Full-Year Reaches $301.8M
13 Jan 2025 //
GLOBENEWSWIRE
BioStem Launches Trial For BioREtain In Treating Foot Ulcers
08 Jan 2025 //
GLOBENEWSWIRE
BioStem Technologies CEO to Present at Biotech Showcase 2025
02 Jan 2025 //
GLOBENEWSWIRE
Kane Biotech Changes US Partner for Revyve™ Antimicrobial Gel
27 Nov 2024 //
GLOBENEWSWIRE
BioStem Announces U.S. Patent Allowance for Placental Allografts
25 Nov 2024 //
GLOBENEWSWIRE
BioStem Technologies Signs LOI To Acquire Wound Care Products
20 Nov 2024 //
GLOBENEWSWIRE
BioStem Technologies Reports Q3 2024 Revenue of $82.6 Million
12 Nov 2024 //
GLOBENEWSWIRE
BioStem Launches Vendaje AC® Nationwide Following Reimbursement
29 Oct 2024 //
GLOBENEWSWIRE
BioStem Technologies Reports Q3 2024 Financial Results Nov. 12
28 Oct 2024 //
#N/A
BioStem Reports Breakthrough In Diabetic Foot Ulcer Study
17 Oct 2024 //
GLOBENEWSWIRE
BioStem Technologies Establishes National Pricing For Vendaje AC
15 Oct 2024 //
GLOBENEWSWIRE
BioStem Initiates BR-AC-DFU-101 Trial for Diabetic Foot Ulcers
02 Oct 2024 //
GLOBENEWSWIRE
BioStem Technologies Files Form 10 & Submits Nasdaq Uplisting
30 Sep 2024 //
GLOBENEWSWIRE
BioStem to Present at H.C. Wainwright Conference in New York on September 9
29 Aug 2024 //
GLOBENEWSWIRE
BioStem Gets IRB Approval For Vendaje Diabetic Foot Ulcer Study
21 Aug 2024 //
GLOBENEWSWIRE
BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million
12 Aug 2024 //
GLOBENEWSWIRE
BioStem Technologies To Report Q2 2024 Results On August 12
05 Aug 2024 //
GLOBENEWSWIRE
BioStem Gets IRB Approval For AmnioWrap2 Study In Diabetic Foot Ulcers
12 Jul 2024 //
BIOSPACE
BioStem Gets IRB Approval For AmnioWrap2 Diabetic Foot Ulcer Study
10 Jul 2024 //
GLOBENEWSWIRE
BioStem Reports Breakthrough Results with AmnioWrap2 in Wound Care Study
26 Jun 2024 //
GLOBENEWSWIRE
BioStem Technologies to Sponsor MRO Better Half Dash
29 May 2024 //
GLOBENEWSWIRE
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
14 May 2024 //
GLOBENEWSWIRE
BioStem To Report Q1 2024 Financial Results On May 14
07 May 2024 //
GLOBENEWSWIRE
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent
06 May 2024 //
GLOBENEWSWIRE
BioStem Hires McCoy To Lead DFU, VLU Trials For BioREtain Allografts
30 Apr 2024 //
GLOBENEWSWIRE
BioStem Technologies to Present at the 2024 Planet MicroCap Showcase
25 Apr 2024 //
GLOBENEWSWIRE
BioStem Completes Audit, Prepares for Uplisting
24 Apr 2024 //
GLOBENEWSWIRE
BioStem to Present at the 14th Annual LD Micro Invitational Conference
02 Apr 2024 //
GLOBENEWSWIRE
BioStem Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
01 Apr 2024 //
GLOBENEWSWIRE
BioStem to Report Q4 FY23 on Monday, April 01, 2024
21 Mar 2024 //
GLOBENEWSWIRE
Amniowrap2 Product Launch Leads Year of Highlights for BioStem Technologies
30 Jan 2024 //
GLOBENEWSWIRE
BioStem Technologies Appoints Shawn McCarrey to Chief Commercial Officer Role
11 Jan 2024 //
GLOBENEWSWIRE
BioStem Appoints Executive Leader Patrick Daly to Board of Directors
19 Dec 2023 //
GLOBENEWSWIRE
Center for Medicare Established National Pricing of AmnioWrap in MAC Regions
14 Dec 2023 //
GLOBENEWSWIRE
BioStem Appointed Thomas Dugan to Board of Directors
13 Dec 2023 //
GLOBENEWSWIRE
BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results
13 Nov 2023 //
GLOBENEWSWIRE
BioStem Technologies Awarded Q Code for VENDAJE AC® Line
08 Nov 2023 //
GLOBENEWSWIRE
BioStem Technologies to Report Third Quarter 2023 Financial Results
06 Nov 2023 //
ACCESSWIRE
BioStem Technologies Closes Oversubscribed $2M Private Placement
03 Nov 2023 //
GLOBENEWSWIRE
BioStem to Highlight Core Advanced Wound Care Portfolio at Fall 2023 Conference
17 Oct 2023 //
ACCESSWIRE
BioStem Awarded a Spot on ECAT, and FSS Contract Vehicles Through SDVOSB, Lovell
06 Sep 2023 //
GLOBENEWSWIRE
BioStem Technologies Commends OIG`s Recommendation for CMS
23 Mar 2023 //
GLOBENEWSWIRE
BioStem to Acquire Majority of Assets of Auxocell Laboratories, Inc.
07 Mar 2023 //
GLOBENEWSWIRE
BioStem Technologies to Acquire Auxocell Labs Assets
07 Mar 2023 //
CONTRACT PHARMA
BioStem Technologies Enters Into a Share Exchange Agreement
14 Feb 2023 //
GLOBENEWSWIRE
BioStem Technologies Poised for Growth with Two New Hires
01 Feb 2023 //
GLOBENEWSWIRE
Center for Medicare Services Established National Pricing of VENDAJETM
24 Jan 2023 //
GLOBENEWSWIRE
BioStem Technologies Announces Up-Listing to the OTCQB Venture Market
16 Dec 2022 //
GLOBENEWSWIRE
BioStem Technologies Announces Partnership with Kill Cliff FC
14 Dec 2022 //
GLOBENEWSWIRE
BioStem Technologies to Host Third Quarter Financial Results
15 Nov 2022 //
GLOBENEWSWIRE
BioStem Technologies Reports Third Quarter 2022 Operating and Financial Results
15 Nov 2022 //
GLOBENEWSWIRE
BioStem Promotes Michael Fortunato, CPA to Chief Financial Officer
26 Oct 2022 //
GLOBENEWSWIRE
BioStem to Present at the Dawson James Securities 2022 Small Cap Growth
10 Oct 2022 //
GLOBENEWSWIRE
BioStem Announces Publication of a Standardized Method to Evaluate Growth
13 Sep 2022 //
GLOBENEWSWIRE
BioStem Technologies Strengthens its Board of Directors and Audit Committee
08 Sep 2022 //
GLOBENEWSWIRE
BioStem Technologies Reports Second Quarter 2022 Financial Results
22 Aug 2022 //
GLOBENEWSWIRE
BioStem Technologies to Q2 Financial Results & Corporate Update Conference Call
16 Aug 2022 //
GLOBENEWSWIRE
BioStem Technologies CEO to Appear on the Benzinga All Access Show
17 Jun 2022 //
GLOBENEWSWIRE
BioStem Technologies Reports March 31, 2022 Record Quarterly Financial Results
16 May 2022 //
GLOBENEWSWIRE
BioStem Technologies Inc. Reports December 31, 2021 Year End Financial Results
01 Apr 2022 //
GLOBENEWSWIRE
